Kameelah Phillips, MD, FACOG, NCMP

Kameelah Phillips, MD, FACOG, NCMP, discusses how health care providers (HCPs) can empower patients to advocate for their health during cervical cancer and sexually transmitted infection (STI) screenings by building trust, fostering open communication about sensitive topics, and striking a balance between sensitivity and thorough screening practices.

The panelist discusses the cautions around recent FDA approvals on human papillomavirus (HPV) self-collection, including limitations and sensitivity while emphasizing the importance of patients continuing to see their OB/GYN regularly.

Kameelah Phillips, MD, FACOG, NCMP, discusses how cervical cancer remains a significant health concern, emphasizing current incidence and prevalence rates, the critical importance of regular screenings in early detection and prevention, and the recommended guidelines for cervical cancer screening during well-woman visits.

The panelist discusses how asymptomatic sexually transmitted infections (STIs) can silently impact overall health, emphasizing the importance of comprehensive screening and education, particularly for less known STIs like trichomoniasis and Mycoplasma genitalium, while exploring how newer testing methods like nucleic acid amplification testing (NAAT) can address challenges in traditional screening access and improve patient care.

Kameelah Phillips, MD, FACOG, NCMP, discusses how advances in molecular testing have improved the diagnosis and management of vaginitis and sexually transmitted infections like Mycoplasma genitalium and trichomoniasis, emphasizing the importance of education and awareness to promote better screening practices.